ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
August 08 2008 - 7:00AM
PR Newswire (US)
Conference call scheduled for August 12, 2008 at 1:30 p.m.
(Pacific); simultaneous webcast at www.adventrx.com SAN DIEGO, Aug.
8 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
(AMEX:ANX) today announced that it will host a conference call with
simultaneous webcast to discuss second quarter 2008 results on
Tuesday, August 12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m.
Eastern. Evan M. Levine, Chief Executive Officer and President, and
Mark N. K. Bagnall, Chief Financial Officer and Executive Vice
President, will host the conference call. The conference call may
be accessed by dialing (888) 215-7027 for domestic callers and
(913) 312-0654 for international callers. The webcast will be
available live via the Internet by accessing ADVENTRX's website at
http://www.adventrx.com/ under "Investors". Replays of the webcast
will be available on ADVENTRX's website for 30 days and a phone
replay will be available through September 12, 2008 by dialing
(888) 203-1112 and entering the pass code 8240633. About ADVENTRX
Pharmaceuticals ADVENTRX Pharmaceuticals is a biopharmaceutical
company focused on in-licensing, developing and commercializing
proprietary product candidates primarily for the treatment of
cancer and infectious disease. The Company seeks to improve the
performance and commercial potential of existing treatments by
addressing problems associated with these treatment regimens. More
information can be found on ADVENTRX's web site at
http://www.adventrx.com/. DATASOURCE: ADVENTRX Pharmaceuticals,
Inc. CONTACT: Investors, Ioana C. Hone of ADVENTRX Pharmaceuticals,
Inc., +1-858-552-0866 Web site: http://www.adventrx.com/
Copyright
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jul 2023 to Jul 2024